Menu Close
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • #JHM Chat
  • Industry Content
    • Patient Monitoring with Tech
An Official Publication of
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • #JHM Chat
  • Industry Content
    • Patient Monitoring with Tech

Hematology (blood)

  • 1
    News

    Idarucizumab reversed dabigatran completely and rapidly in study

    July 11, 2017

    One drug reversed the anticoagulant effect of another completely and rapidly.

  • 1
    News

    Application of the MASCC and CISNE risk-stratification scores to identify low-risk febrile neutropenic patients in the emergency department

    June 12, 2017

    Does the Multinational Association for Supportive Care in Cancer (MASCC) or Clinical Index of Stable Febrile Neutropenia (CISNE) risk-stratification score better predict patient outcomes in patients presenting to emergency departments with febrile neutropenia?

  • 1
    News

    Low-dose aspirin bests dual-antiplatelet therapy in TAVR

    June 8, 2017

    PARIS – ARTE trial is hailed as practice changing.

  • 1
    News

    Consider switch to clopidogrel for DAPT early post ACS

    May 20, 2017

    PARIS – TOPIC trial provides new evidence-based DAPT strategy.

  • 1
    News

    What are indications, complications of acute blood transfusions in sickle cell anemia? Key Points Additional Reading

    March 17, 2017

    Transfusion has many serious and life-threatening potential adverse effects; conduct thorough risk-benefit analysis for each individual sickle cell patient. Whenever possible, intensive phenotypically matched and leukoreduced RBCs should be used.

  • 1
    News

    Taking the hammer to sickle pain crises

    February 1, 2017

    Clinical question: Are any novel medicines designed to interrupt the pathophysiology of vaso-occlusion available to reduce the frequency and severity of pain crises in sickle cell anemia?

  • Article

    Blood thinning with bioprosthetic valves

    January 10, 2017

    Blood thinning with bioprosthetic valvesClinical question: Does anticoagulation prevent thromboembolic events in patients undergoing bioprosthetic valve implantation?Background: The main advantage of bioprosthetic valves, compared with mechanical valves, is the avoidance of long-term anticoagula...

  • News

    Increased death rate with platelets for aspirin/clopidogrel GI bleed

    November 28, 2016

    Patients with normal platelet counts who have a GI bleed while on antiplatelets were almost six times more likely to die in the hospital if they had a platelet transfusion, in a retrospective cohort study from the Yale University.

Previous1 … 11 12 13
  • About The Hospitalist
  • Contact Us
  • The Editors
  • Editorial Board
  • Authors
  • Publishing Opportunities
  • Subscribe
  • Advertise
fa-facebookfa-linkedinfa-instagramfa-youtube-playfa-commentfa-envelopefa-rss
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies.
    ISSN 1553-085X
  • Privacy Policy
  • Terms and Conditions
  • SHM’s DE&I Statement
  • Cookie Preferences